neoscreen.online
BRCA1 and BRCA2
€330
It involves the control of the BRCA 1 and BRCA 2 genes, with NGS (Miseq, Illumina) and MLPA, covering 100% of these mutations, to which the inherited breast-ovarian syndrome is due.
Response Time 3-4 weeks.